CA2078901A1 - Method for treating hypertension - Google Patents
Method for treating hypertensionInfo
- Publication number
- CA2078901A1 CA2078901A1 CA002078901A CA2078901A CA2078901A1 CA 2078901 A1 CA2078901 A1 CA 2078901A1 CA 002078901 A CA002078901 A CA 002078901A CA 2078901 A CA2078901 A CA 2078901A CA 2078901 A1 CA2078901 A1 CA 2078901A1
- Authority
- CA
- Canada
- Prior art keywords
- hypertension
- compound
- composition according
- formula
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Removal Of Specific Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/765,643 US5175179A (en) | 1991-09-25 | 1991-09-25 | Method for treating hypertension |
| US765,643 | 1991-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2078901A1 true CA2078901A1 (en) | 1993-03-26 |
Family
ID=25074097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002078901A Abandoned CA2078901A1 (en) | 1991-09-25 | 1992-09-23 | Method for treating hypertension |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5175179A (enExample) |
| EP (1) | EP0534655B1 (enExample) |
| JP (1) | JPH05194220A (enExample) |
| KR (1) | KR950013756B1 (enExample) |
| AT (1) | ATE124259T1 (enExample) |
| AU (1) | AU644545B2 (enExample) |
| CA (1) | CA2078901A1 (enExample) |
| DE (1) | DE69203194T2 (enExample) |
| DK (1) | DK0534655T3 (enExample) |
| ES (1) | ES2073871T3 (enExample) |
| HU (1) | HUT65276A (enExample) |
| IL (1) | IL103202A0 (enExample) |
| MX (1) | MX9205408A (enExample) |
| MY (1) | MY129918A (enExample) |
| NZ (1) | NZ244474A (enExample) |
| TW (1) | TW209167B (enExample) |
| ZA (1) | ZA927307B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| CA2577084A1 (en) * | 2004-08-25 | 2006-03-02 | Olivier Bezencon | Bicyclononene derivatives as renin inhibitors |
| AU2006253805A1 (en) * | 2005-05-27 | 2006-12-07 | Actelion Pharmaceuticals Ltd. | Novel piperidine carboxylic acid amide derivatives |
| NZ571595A (en) * | 2006-03-08 | 2010-06-25 | Actelion Pharmaceuticals Ltd | New amines |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989008651A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| GB8919417D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
| US5053420A (en) * | 1989-10-13 | 1991-10-01 | Pershadsingh Harrihar A | Thiazolidine derivatives for the treatment of hypertension |
| US5036079A (en) * | 1989-12-07 | 1991-07-30 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| JP2826379B2 (ja) * | 1990-01-22 | 1998-11-18 | 三共株式会社 | チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤 |
| ATE93138T1 (de) * | 1990-02-09 | 1993-09-15 | Upjohn Co | Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie. |
-
1991
- 1991-09-25 US US07/765,643 patent/US5175179A/en not_active Expired - Fee Related
-
1992
- 1992-07-29 TW TW081106014A patent/TW209167B/zh active
- 1992-09-02 JP JP4234742A patent/JPH05194220A/ja active Pending
- 1992-09-14 EP EP92308333A patent/EP0534655B1/en not_active Expired - Lifetime
- 1992-09-14 AT AT92308333T patent/ATE124259T1/de not_active IP Right Cessation
- 1992-09-14 ES ES92308333T patent/ES2073871T3/es not_active Expired - Lifetime
- 1992-09-14 DK DK92308333.1T patent/DK0534655T3/da active
- 1992-09-14 DE DE69203194T patent/DE69203194T2/de not_active Expired - Fee Related
- 1992-09-17 IL IL103202A patent/IL103202A0/xx unknown
- 1992-09-23 CA CA002078901A patent/CA2078901A1/en not_active Abandoned
- 1992-09-23 AU AU25326/92A patent/AU644545B2/en not_active Ceased
- 1992-09-23 MX MX9205408A patent/MX9205408A/es unknown
- 1992-09-23 MY MYPI92001700A patent/MY129918A/en unknown
- 1992-09-24 KR KR1019920017395A patent/KR950013756B1/ko not_active Expired - Lifetime
- 1992-09-24 NZ NZ244474A patent/NZ244474A/en unknown
- 1992-09-24 HU HU9203052A patent/HUT65276A/hu unknown
- 1992-09-24 ZA ZA927307A patent/ZA927307B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2073871T3 (es) | 1995-08-16 |
| HU9203052D0 (en) | 1992-12-28 |
| MX9205408A (es) | 1993-03-01 |
| DK0534655T3 (da) | 1995-08-28 |
| KR930005621A (ko) | 1993-04-20 |
| DE69203194T2 (de) | 1995-11-02 |
| EP0534655A1 (en) | 1993-03-31 |
| MY129918A (en) | 2007-05-31 |
| HUT65276A (en) | 1994-05-02 |
| US5175179A (en) | 1992-12-29 |
| KR950013756B1 (ko) | 1995-11-15 |
| DE69203194D1 (de) | 1995-08-03 |
| AU2532692A (en) | 1993-04-22 |
| JPH05194220A (ja) | 1993-08-03 |
| TW209167B (enExample) | 1993-07-11 |
| IL103202A0 (en) | 1993-02-21 |
| ATE124259T1 (de) | 1995-07-15 |
| AU644545B2 (en) | 1993-12-09 |
| EP0534655B1 (en) | 1995-06-28 |
| ZA927307B (en) | 1994-03-24 |
| NZ244474A (en) | 1994-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3043430B2 (ja) | ２−アルキルピロリジン類 | |
| US6329408B1 (en) | Hypoglycemic thiazolidinediones and intermediates | |
| HK64089A (en) | Medicinal compositions comprising as an active ingredient substituted 1,4-benzoquinones | |
| JPH04210683A (ja) | チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 | |
| FR2516083A1 (fr) | Derives de l'ergoline, procede pour leur preparation et medicaments les contenant | |
| KR840001553B1 (ko) | 시클로헥센 유도체의 제조방법 | |
| US5175179A (en) | Method for treating hypertension | |
| EP0097453A2 (en) | Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity | |
| CA1313139C (en) | D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl] thiazolidine-2,4-dione as an anti-atherosclerosis agent | |
| HU199845B (en) | Process for producing new spiro/chroman-4,4'-imidazolidine derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| CA1050996A (en) | Antidiabetic agent, "isoxazole derivatives" | |
| JP2687398B2 (ja) | アルドースリダクターゼ阻害剤 | |
| US4482568A (en) | Inhibition of alcohol metabolism by tetramethylene sulfoxides | |
| US20060241163A1 (en) | Optically active (S)-hydantoin derivative | |
| GB2378652A (en) | Steroidal medicament for the treatment of diabetes | |
| CH681983A5 (enExample) | ||
| US20060241162A1 (en) | Optically active (R)-hydantoin derivative | |
| CH647503A5 (fr) | Derives de la 16-methoxy-16-methyl-prostaglandine e(1), procede pour leur synthese et medicaments gastro-protecteurs contenant lesdits derives. | |
| GB2202849A (en) | Substituted 1,3-dioxolane and 1,3-dioxane derivatives, processes for the production and their use | |
| LU82829A1 (fr) | Nouveaux derives de 16-methoxy-16-methyl-prostaglandine e1,leur procede de preparation et leur utilisation comme agents gastroprotecteurs | |
| FR2845383A1 (fr) | Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |